SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-188165
Filing Date
2023-07-17
Accepted
2023-07-17 16:49:04
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d519578d424b5.htm 424B5 474459
2 GRAPHIC g519578g01a02.jpg GRAPHIC 45410
3 GRAPHIC g519578g25s01.jpg GRAPHIC 105099
4 GRAPHIC g519578g25s02.jpg GRAPHIC 77214
  Complete submission text file 0001193125-23-188165.txt   773739
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266004 | Film No.: 231092077
SIC: 2836 Biological Products, (No Diagnostic Substances)